Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin prophylaxis in paediatric ALL
NCT04678869Active, not recruiting
- Sponsor
- University College London
- Start
- Jun 2022
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ciprofloxacin in bacterial infection, sponsored by University College London. Primary endpoint: Rate of sterile site bacterial infections during induction at 1 month. Started Jun 2022; status: active, not recruiting.
02
Drugs
ciprofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04678869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04678869.